OGN:NYSE
Organon & Co
13,76 $
arrow_upward
+0,04%(+0,0050) 1D
9 հոկ, 11:25:35 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
13,76 $
High
13,78 $
Low
13,75 $
Mkt. cap
3,61 մլրդ
Avg. vol.
2,60 մլն
Volume
366,60 հզր
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,62
52-wk high
13,80 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
Open
13,76 $
High
13,78 $
Low
13,75 $
Mkt. cap
3,61 մլրդ
Avg. vol.
2,60 մլն
Volume
366,60 հզր
Dividend
0,58%
Quarterly dividend
0,02 $
Ex-dividend date
14 օգս, 2026 թ.
P/E ratio
17,62
52-wk high
13,80 $
52-wk low
5,69 $
EPS
0,78 $
Beta
1,55
Shares outstanding
262,61 մլն
No. of employees
10 հզր
News stories
From web sources and news partners
Coinfomania
·
13 ժամ առաջ
Unexpected Turn: OGN Price Falls 13.02% in Just One Hour
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 հզր
Founded1923
HeadquartersՋերսի Սիթի, Նյու Ջերսի, Միացյալ Նահանգներ
Sector-
Websiteorganon.com